Bonesupport Holding AB (publ) (STO:BONEX)

Market Cap	19.77B
Revenue (ttm)	1.06B
Net Income (ttm)	147.98M
Shares Out	65.86M
EPS (ttm)	2.22
PE Ratio	135.30
Forward PE	69.30
Dividend	n/a
Ex-Dividend Date	n/a

Volume	766
Average Volume	103,693
Open	300.60
Previous Close	300.20
Day's Range	300.00 - 300.80
52-Week Range	244.00 - 405.80
Beta	0.60
RSI	46.63
Earnings Date	Oct 23, 2025

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute t...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1999
• Employees: 139
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BONEX

Financial Performance

In 2024, Bonesupport Holding AB's revenue was 898.73 million, an increase of 52.05% compared to the previous year's 591.08 million. Earnings were 133.75 million, a decrease of -45.41%.